Literature DB >> 30808831

Group B Streptococcus Colonization in Late Pregnancy and Invasive Infection in Neonates in China: A Population-Based 3-Year Study.

Yao Zhu1, Jing Huang1, Xin-Zhu Lin2, Chao Chen3.   

Abstract

BACKGROUND: As no population-based studies of group B Streptococcus (GBS) colonization rates in late pregnancy (at 35-37 weeks of gestation) have been conducted in China, the incidence of and risk factors for neonatal early-onset GBS disease (GBS-EOD) in China remains poorly understood.
OBJECTIVES: To determine the GBS colonization rate in late pregnancy and neonatal GBS infection in Xiamen, China, and to assess the effectiveness of intrapartum antibiotic prophylaxis (IAP) for the prevention of neonatal GBS-EOD.
METHODS: A total of 49,908 pregnant women were enrolled between April 1, 2014 and March 31, 2017. Bacterial culture was used to diagnose GBS infection in both pregnant women and neonates. Women with GBS colonization received IAP during parturition or rupture of fetal membranes.
RESULTS: The GBS colonization rate was 13.89% (6,933/49,908); 50,772 neonates were born to 49,908 pregnant women, of whom 75 (1.48 per 1,000) were diagnosed with GBS-EOD. The incidence of GBS-EOD among neonates born to GBS-positive mothers (8.77‰; 62/7,068) was 29 times higher than that of neonates born to GBS-negative mothers (0.30‰; 13/43,704). Logistic regression analysis indicated that gestational bacteriuria, GBS disease in infants from previous pregnancies, and chorioamnionitis were risk factors for GBS-EOD (p = 0.007, p = 0.000, and p = 0.018, respectively). IAP effectively protected against neonatal GBS-EOD (p = 0.011).
CONCLUSIONS: GBS colonization was detected in nearly 14% of late pregnant women. The IAP for reducing GBS-EOD was effective. Therefore, universal screening of maternal GBS and subsequent IAP for those with GBS colonization should be implemented in China.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Group B Streptococcus; Group B Streptococcus early-onset disease; Late pregnancy; Neonate

Year:  2019        PMID: 30808831     DOI: 10.1159/000494133

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  5 in total

1.  Biomarkers for a histological chorioamnionitis diagnosis in pregnant women with or without group B streptococcus infection: a case-control study.

Authors:  Jie Ren; Zhe Qiang; Yuan-Yuan Li; Jun-Na Zhang
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-25       Impact factor: 3.007

2.  Uvaol Prevents Group B Streptococcus-Induced Trophoblast Cells Inflammation and Possible Endothelial Dysfunction.

Authors:  Ana Lucia Mendes Silva; Elaine Cristina Oliveira Silva; Rayane Martins Botelho; Liliane Patricia Gonçalves Tenorio; Aldilane Lays Xavier Marques; Ingredy Brunele Albuquerque Costa Rodrigues; Larissa Iolanda Moreira Almeida; Ashelley Kettyllem Alves Sousa; Keyla Silva Nobre Pires; Ithallo Sathio Bessoni Tanabe; Marie-Julie Allard; Guillaume Sébire; Samuel Teixeira Souza; Eduardo Jorge Silva Fonseca; Karen Steponavicius Cruz Borbely; Alexandre Urban Borbely
Journal:  Front Physiol       Date:  2021-12-03       Impact factor: 4.566

3.  Prevalence and Risk Factors of Group B Streptococcus Colonization in Pregnant Women: A Pilot Study in Palestine.

Authors:  Mohammad Qadi; Adham AbuTaha; Ro'ya Al-Shehab; Salsabil Sulaiman; Abdallah Hamayel; Amjad Hussein; Shatha AbuTaha; Ayman Dawoud; Faizeh Hussein
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-12-13       Impact factor: 2.471

4.  Clinical Profile and Risk Factors of Group B Streptococcal Colonization in Mothers from the Eastern District of China.

Authors:  Jin Jiao; Weiwei Wu; Feng Shen; Zhongyuan Liu; Huiru Zhou; Gang Fan; Yuxia Zhou
Journal:  J Trop Med       Date:  2022-08-29

5.  Identification of Group B Streptococcus Serotypes and Genotypes in Late Pregnant Women and Neonates That Are Associated With Neonatal Early-Onset Infection in a South China Population.

Authors:  Zhu Yao; Wu Jiayin; Zheng Xinyi; Chen Ling; He Mingyuan; Ma Simin; Lin Yayin; Lin Xinzhu; Chen Chao
Journal:  Front Pediatr       Date:  2020-05-27       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.